These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6206634)

  • 1. [Importance of various factors in the occurrence of prostatic cancer].
    Chaklin AV; Plotnikov SV
    Urol Nefrol (Mosk); 1984; (4):46-51. PubMed ID: 6206634
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal signaling in prostatic hyperplasia and neoplasia.
    Marcelli M; Cunningham GR
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3463-8. PubMed ID: 10522981
    [No Abstract]   [Full Text] [Related]  

  • 3. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphological variants of prostatic endocrine diseases in old age].
    Derevianko IM; Batchaev SU; Shelegeda AS
    Urol Nefrol (Mosk); 1978; (6):22-6. PubMed ID: 82284
    [No Abstract]   [Full Text] [Related]  

  • 5. Etiological and epidemiological considerations in prostatic cancer.
    Bouffioux CR
    Scand J Urol Nephrol Suppl; 1980; 55():9-16. PubMed ID: 6938042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of stromal tissue in benign prostatic hyperplasia: morphological, immunofluorescence and endocrinological investigations.
    Bartsch G; Brüngger A; Schweikert U; Hintner H; Stanzl U; Marth C; Daxenbichler G; Rohr HP
    Prog Clin Biol Res; 1984; 145():159-79. PubMed ID: 6201873
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is there a hormonal etiology in prostatic hypertrophy?].
    Robel P
    Ann Urol (Paris); 1985; 19(3):151-2. PubMed ID: 2411205
    [No Abstract]   [Full Text] [Related]  

  • 8. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia.
    Lagiou A; Samoli E; Georgila C; Minaki P; Barbouni A; Tzonou A; Trichopoulos D; Lagiou P
    Eur J Cancer Prev; 2008 Aug; 17(4):336-9. PubMed ID: 18562958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: review of epidemiologic literature.
    Neuhouser ML; Kristal AR; Penson DF
    Urology; 2004 Aug; 64(2):201-11. PubMed ID: 15302461
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case-control study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang].
    Ning X; Shi JP; Wu ZY; Zheng LG; Wang HL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):276-80. PubMed ID: 12820944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostate cancer--incidence and risk factors].
    Brasso K
    Ugeskr Laeger; 2007 May; 169(20):1883-6. PubMed ID: 17553361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer of the prostate].
    Bouffioux C
    Acta Urol Belg; 1979 Apr; 47(2):189-470. PubMed ID: 90455
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate cancer. Epidemiology.
    Alderson MR
    Recent Results Cancer Res; 1981; 78():1-19. PubMed ID: 6168010
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypothesis: gonadal hormones act as confounders in epidemiological studies of the associations between some behavioural risk factors and some pathological conditions.
    James WH
    J Theor Biol; 2001 Mar; 209(1):97-102. PubMed ID: 11237573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer of the prostate. 1. Epidemiology].
    Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
    Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgenic hormones and prostate cancer risk: status and prospects.
    Gann PH
    IARC Sci Publ; 2002; 156():283-8. PubMed ID: 12484188
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical, life-style, and occupational risk factors for prostate cancer.
    Checkoway H; DiFerdinando G; Hulka BS; Mickey DD
    Prostate; 1987; 10(1):79-88. PubMed ID: 2434937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The incidences of benign prostatic hyperplasia and prostatic cancer in China].
    Gu FL
    Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):323-6. PubMed ID: 7508844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of prostatic hyperplasia and neoplasia.
    Roberts HJ
    Geriatrics; 1967 Dec; 22(12):85-92. PubMed ID: 4168607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.